Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing compound containing saccharide radical
Reexamination Certificate
2007-05-29
2007-05-29
Nashed, Nashaat T. (Department: 1656)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing compound containing saccharide radical
C435S072000, C435S101000
Reexamination Certificate
active
10642248
ABSTRACT:
The present invention relates to methodology for polymer grafting by a polysaccharide synthase and, more particularly, polymer grafting using the hyaluronate or chondroitin or heparin/heparosan synthases fromPasteurella, in order to create a variety of glycosaminoglycan oligosaccharides having a natural or chimeric or hybrid sugar structure with a targeted size that are substantially monodisperse in size.
REFERENCES:
patent: 4224179 (1980-09-01), Schneider
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4511478 (1985-04-01), Nowinski et al.
patent: 4517295 (1985-05-01), Bracke et al.
patent: 4585754 (1986-04-01), Meisner et al.
patent: 4615697 (1986-10-01), Robinson
patent: 4708861 (1987-11-01), Popescu et al.
patent: 4780414 (1988-10-01), Nimrod et al.
patent: 4782046 (1988-11-01), Brown et al.
patent: 4784990 (1988-11-01), Nimrod et al.
patent: 4801539 (1989-01-01), Akasaka et al.
patent: 4822867 (1989-04-01), Erhan
patent: 4983392 (1991-01-01), Robinson
patent: 4990601 (1991-02-01), Skjak-Braek et al.
patent: 5008253 (1991-04-01), Casu et al.
patent: 5015577 (1991-05-01), Weigel et al.
patent: 5023175 (1991-06-01), Hosoya et al.
patent: 5071751 (1991-12-01), Morita et al.
patent: 5171689 (1992-12-01), Kawaguri et al.
patent: 5217743 (1993-06-01), Farah
patent: 5314876 (1994-05-01), Lormeau et al.
patent: 5337747 (1994-08-01), Neftel
patent: 5384398 (1995-01-01), Lormeau et al.
patent: 5472704 (1995-12-01), Santus et al.
patent: 5473034 (1995-12-01), Yasui et al.
patent: 5607694 (1997-03-01), Marx
patent: 5610241 (1997-03-01), Lee et al.
patent: 5622850 (1997-04-01), Sloma et al.
patent: 5631019 (1997-05-01), Marx
patent: 5651982 (1997-07-01), Marx
patent: 5876433 (1999-03-01), Lunn
patent: 5948900 (1999-09-01), Yother et al.
patent: 5958899 (1999-09-01), Zoppetti et al.
patent: 6120536 (2000-09-01), Ding et al.
patent: 6156373 (2000-12-01), Zhong et al.
patent: 6162797 (2000-12-01), Zoppetti et al.
patent: RE37336 (2001-08-01), Weigel et al.
patent: 6423514 (2002-07-01), Briskin
patent: 2003/0100534 (2003-05-01), Zoppetti et al.
patent: 0195303 (1989-11-01), None
patent: 0144019 (1990-06-01), None
patent: 0266578 (1993-07-01), None
patent: 0244757 (1994-11-01), None
patent: 00300035 (1995-05-01), None
patent: 0036776 (1998-05-01), None
patent: 01304338 (2003-04-01), None
patent: 2249315 (1992-05-01), None
patent: 61-257169 (1986-11-01), None
patent: 62032893 (1987-02-01), None
patent: 63094988 (1988-04-01), None
patent: 4-80202 (1992-03-01), None
patent: 4-124854 (1992-04-01), None
patent: 4-134854 (1992-05-01), None
patent: 4-158796 (1992-06-01), None
patent: 8-38336 (1996-02-01), None
patent: 91/03559 (1991-03-01), None
patent: 94/00463 (1994-01-01), None
patent: 95/24497 (1995-09-01), None
patent: 95/33067 (1995-12-01), None
patent: 97/20061 (1997-06-01), None
patent: 00/27437 (2000-05-01), None
patent: 01/02597 (2001-01-01), None
patent: WO 01/80810 (2001-11-01), None
patent: WO 03/012099 (2003-02-01), None
Paul L. DeAngelis, “Molecular Directionality of Polysaccharide Polymerization by thePasteurella multocidaHyaluronan Synthase”, J. Biological Chemistry, vol. 274: 26557-26562 (1999).
C. Heldermon, K. Kumari, V. Tlapak-Simons & P. Weigel, “Streptococcal hyaluronan synthase and the synthesis of ‘designer’ hyaluronan”, Elsevier Science, 41-50 (2000).
W. Jing & P. DeAngelis, “Synchronized Chemoenzymatic Synthesis of Monodisperse Hyaluronan Polymers”, J. Biological Chemistry, vol. 279: 42345-42349 (2004).
“The Combinations of Haemoglobin With Oxygen and With Carbon Monoxide.”, Hill, J. Biochem., 7:471-480 (1913).
“Die Kinetik Der Invertinwirkung”, Michaelis and Menten, Biochem. Z., 49: 333-338 (1913) (No translation available).
“The Role of the Mucoid Polysaccharide (Hyaluronic Acid) in the Virulence of Group A Hemolytic Streptococci”, Kass et al., J. Of Exp. Med., 79:319-330 (1944).
“The Production of Capsules, Hyaluronic Acid and Hyaluronidase by Group A and Group C Streptocooci”, MacLennan, J. Gen. Microbiol., 14:134-142 (1956).
“The Isolation and Characterization of a Hyaluronidase Produced by a Capsulated Strain of Group CStreptococcus”, MacLennan, J. Gen. Microbiol., 14:143-152 (1956).
“The Biosynthesis of Hyaluronic Acid by Group AStreptococcus”, Markovitz et al., J. Biol. Chem., 234 (9):2343-2350 (1959).
“The Biosynthesis of Hyaluronic Acid byStreptococcus,” Stoolmiller, et al., Journal of Biological Chemistry, vol. 244, No. 2, pp. 236-246 (1969).
“Cleavage of Structural Proteins During the Assembly of the Head of Bacteriophage T4”, Laemmli, Nature, 227:680-685 (1970).
“The Isolation and Characterization of Hyaluronic Acid FromPasteurella multocida”, Cifonelli, et al., Carbohydrate Research, 14, 272-276, (1970).
“A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding”, Bradford, Analytical Biochemistry, 72:248-254 (1976).
“Genetic Mapping of the K1 and K4 Antigens (L) ofEscherichia coli. Non-Allelism of K(L) Antigens With K Antigens of O8:KB (L) and O9:K57 (B)”, Orskov et al., Acta Pathol Microbiol Scand B, 84:125-131 (1976).
“Synthesis and Assembly of the Membrane Proteins inE. coli”, Ito et al., Cell, 11:551-559 (1977).
“Electrophoretic Transfer of Proteins From Polyacrylamide Gels to Nitrocellulose Sheets: Procedure and Some Applications”, Biochemistry, 76: 4350-4354 (1979).
“Biosynthesis of Hyaluronic Acid byStreptococcus”, Sugahara et al., J. Biol. Chem., 254:6252-6261 (1979).
“Modern Genetics”, Ayala, et al., Benjamin/Cummings Publishing Col., Menlo Park CA, p. 45 (1980).
“Hyaluronidase Production by Type BPasteurella multocidaFrom Cases of Hemorrhagic Septicemia”, Carter, et al., Journal of Clinical Microbiology, p. 94-96, (1980).
“Hyaluronate Capsule Prevents Attachment of Group A Streptococci to Mouse Peritoneal Macrophages”, Whitnack et al., Infection and Immunity, 31(3):985-991 (1981).
“Strains ofEscherichia coliCarrying the Structural Gene for Histidyl-tRNA Synthetase on a High Copy-Number Plasmid”, Eisenbeis, et al., Mol. Gen. Genet. 183:115-122 (1981).
“The Structure of the Capsular Polysaccharide (K5 Antigen) of Urinary-Tract-InfectiveEscherichia coli010:K5:H4”, Vann et al., Biochem J. 116:359-364 (1981).
“Synthesis of Hyaluronate in Differentiated Teratocarcinoma Cells,” Prehm, et al., J. Biochem, vol. 211, pp. 181-189 (1983).
“Streptococcal Hyaluronic Acid: Proposed Mechanisms of Degradation and Loss of Synthesis During Stationary Phase”, Van de Rijn, J. Bacteriol., 156(3):1059-1065 (1983).
“Differences in the Effects of pH on the Hydrolytic and Transgalactosylic Reactions of Beta-Galactosidase (Escherichia coli)”, Huber et al., Can. J. Biochem. Cell Biol., 61:198-206 (1983).
“Hyaluronate is Synthesized at Plasma Membranes”, Prehm, Biochem. J., 220:597-600 (1984).
“Subcellular Locations of Hyaluronate Synthase in Oligodendroglioma Cells”, Philipson et al., J. Biol. Chem., 259(8):5017-5023 (1984).
“Binding and Reactivity at the ‘Glucose’ Site of Galactosyl-Beta-Galactosidase (Escherichia coli)”, Huber et al., Arch Biochem Biophys., 234: 151-160 (1984).
“Heparin, Its Fractions, Fragments and Derivatives. Some Newer Perspectives”, Fareed, Seminars in Thrombosis and Hemostasis. 11(1):1-9 (1985).
“Solubilization of Hyaluronic Acid Synthetic Activity From Streptococci and its Activation With Phospholipids”, Triscott et al., J. Biol. Chem., 261(13):6004-6009 (1986).
“Isolation of Streptococcal Hyaluronate Synthase”, Prehm et al., Biochem. J., 235:887-889 (1986).
“Effect of Replacing Uridine 33 in Yeast tRNAPhe on the Reaction With Ribosomes”, Dix et al., J. Biol. Chem., 261(22):10112-8 (19
DeAngelis Paul L.
Jing Wei
Dunlap Codding & Rogers P.C.
Nashed Nashaat T.
The Board of Regents of the Universtiy of Oklahoma
LandOfFree
Targeted glycosaminoglycan polymers by polymer grafting and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeted glycosaminoglycan polymers by polymer grafting and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted glycosaminoglycan polymers by polymer grafting and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3756899